HCP
PBH icon

Hexagon Capital Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Hexagon Capital Partners’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-254
Closed -$21.8K – 1235
2025
Q1 		$21.8K Buy
254
+71
+39% +$5.82K ﹤0.01% 727
2024
Q4 		$14.3K Buy
183
+22
+14% +$1.71K ﹤0.01% 899
2024
Q3 		$11.6K Buy
161
+25
+18% +$1.77K ﹤0.01% 875
2024
Q2 		$9.36K Sell
136
-10
-7% -$677 ﹤0.01% 893
2024
Q1 		$10.6K Sell
146
-7
-5% -$468 ﹤0.01% 846
2023
Q4 		$9.37K Sell
153
-17
-10% -$1.01K ﹤0.01% 843
2023
Q3 		$9.72K Buy
170
+42
+33% +$2.54K ﹤0.01% 755
2023
Q2 		$7.61K Sell
128
-16
-11% -$957 ﹤0.01% 812
2023
Q1 		$9.02K Sell
144
-45
-24% -$2.81K ﹤0.01% 754
2022
Q4 		$11.8K Buy
189
+6
+3% +$344 ﹤0.01% 678
2022
Q3 		$9K Buy
183
+131
+252% +$7.25K ﹤0.01% 802
2022
Q2 		$3K Buy
+52
New +$2.87K ﹤0.01% 910

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hexagon Capital Partners's PBH Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Prestige Consumer Healthcare (PBH) in Q2 2025, closing a stake of 254 shares — an estimated $21.8K sold.

Hexagon Capital Partners first reported a position in PBH in Q2 2022 and held it in 12 quarters. The position peaked at $21.8K in Q1 2025. 378 funds tracked by Wall St. Rank hold PBH as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Prestige Consumer Healthcare position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 254 Prestige Consumer Healthcare shares in Q2 2025, an estimated $21.8K.
  • Hexagon Capital Partners first reported a position in Prestige Consumer Healthcare in Q2 2022 and held it in 12 quarters.
  • Hexagon Capital Partners's Prestige Consumer Healthcare position peaked at $21.8K in Q1 2025.
  • 378 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.